Zenotech Laboratorie

ZENOTECH

Price
Micro Cap
₹372 Cr.
Zenotech Laboratories Ltd develops and manufactures generic biopharmaceuticals to address unmet medical needs worldwide. They offer services for generating and characterizing recombinant proteins, including gene cloning, expression, process development, and assay validation. Their product range includes generics, chemicals like Gemcitabine and Paclitaxel, a… More
Zenotech Laboratories Ltd develops and manufactures generic biopharmaceuticals to address unmet medical needs worldwide. They offer services for generating and characterizing recombinant proteins, including gene cloning, expression, process development, and assay validation. Their product range includes generics, chemicals like Gemcitabine and Paclitaxel, and new biological entities in Cancer and Neurology. Less
Zenotech Laboratories Ltd develops and manufactures generic biopharmaceuticals to address unmet med… More
Zenotech Laboratories Ltd develops and manufactures generic biopharmaceuticals to address unmet medical needs worldwide. They offer services for generating and characterizing recombinant proteins, including gene cloning, expression, process development, and assay validation. Their product range includes generics, chemicals like Gemcitabine and Paclitaxel, and new biological entities in Cancer and Neurology. Less
Low
51.00
52W Range
High
108
PE
74.54
Sector PE
25.8
P/B
3.99
Div.Yield
--
ROE
9.17%
EBIDTA
28.02
ROCE
12.93
EPS
0.28

Recent events

  • News

  • Corporate Actions

Zenotech Laboratories Names Sachin Laxmanappa Gavandare As CEO

Oct 23, 2024

Events:

Announcement Date
Jan 28, 2025
Announcement Date
Oct 23, 2024
Announcement Date
Sep 02, 2024
Announcement Date
Jul 26, 2024
Announcement Date
Jan 29, 2024
Announcement Date
Oct 30, 2023
Announcement Date
Sep 06, 2023
Announcement Date
Aug 01, 2023
Announcement Date
Apr 28, 2023
Announcement Date
Jan 27, 2023
Announcement Date
Oct 28, 2022
Announcement Date
Aug 30, 2022
Announcement Date
Jul 22, 2022
Announcement Date
Apr 29, 2022
Announcement Date
Jan 28, 2022
Announcement Date
Oct 22, 2021
Announcement Date
Jul 24, 2021
Announcement Date
May 01, 2021
Announcement Date
Jan 23, 2021
Announcement Date
Oct 31, 2020
Announcement Date
Jul 25, 2020
Announcement Date
May 23, 2020
Announcement Date
Feb 01, 2020

Rights

17 rights eligible for every 22 shares held.
Ex Date
Jun 01, 2017

More Micro Cap Ideas

See similar 'Micro' cap companies with recent activity

Promoter Buying

Companies where the promoters are bullish

Capex

Companies investing on expansion

Superstar Investor

Companies where well known investors have invested